Atraumatic osteonecrosis of the humeral head after influenza A-(H1N1) v-2009 vaccination

Vaccine

Volumn 29, Issue 40, 2011, Pages 6830-6833

  Kuether, G ^a   Dietrich, B ^b   Smith, T ^a   Peter, C ^a   Gruessner, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Frederikenstift Hannover ^*  (Germany)

Author keywords

Adverse event; Atraumatic osteonecrosis; Influenza A (H1N1) v 2009 vaccination

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; IBUPROFEN; INFLUENZA VACCINE; PARACETAMOL;

ADULT; ANALGESIA; ARTICLE; BONE NECROSIS; BONE PAIN; CASE REPORT; FEMALE; HUMAN; HUMERUS HEAD; HUMERUS HEAD OSTEONECROSIS; INFLUENZA A (H1N1); INFLUENZA VACCINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRIORITY JOURNAL; SHOULDER IMPINGEMENT SYNDROME;

ADJUVANTS, IMMUNOLOGIC; BURSITIS; FEMALE; HUMANS; HUMERAL HEAD; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; OSTEONECROSIS;

EID: 80052304722     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.07.052     Document Type: Article

References (43)

1. World Health Organization. WHO recommendations on pandemic (H1N1) 2009 Vaccines. http://www.who.int/csr/disease/swineflu/notes/h1n1_vaccine_2009713/en/index.html.
2. Clark T.W., Pareek M., Hoschler K., Dillon H., Nicholson K.G., Groth N., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Eng J Med 2009, 361:2424-2435.
3. Liang X.F., Wang H.Q., Wang J.Z., Fang H.H., Wu J., Zuh F.C., et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomized, placebo-controlled trial. Lancet 2010, 375:56-66.
4. Andrews N., Waight P., Yung C.F., Miller E. Age-specific effectiveness of an oil-in-water adjuvanted pandemic (H1N1) 2009 vaccine against confirmed infection in high risk groups in England. J Infect Dis 2011, 203:32-39.
5. Leroux-Roels I., Borkowski A., Vanwolleghem T., Drame M., Clement F., Hans E., et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomized controlled trail. Lancet 2007, 370:580-588.
6. Chu D., Hwang S.J., Lim F.S., Oh H.M., Thongcharoen P., Yang P.C., et al. Immunogenicity and tolerability of an AS03A-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults. Vaccine 2009, 27:7428-7435.
7. Schwarz T.F., Horacek T., Knuf M., Damman H.G., Roman F., Dramé M., et al. Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine 2009, 27:6284-6290.
8. Robert Koch Institut. Mitteilungen der Ständigen Impfkommission (STIKO) am Robert Koch Institut. Epid Bull 2010; 31:299-309.
9. Prestel J., Mentzer D., Keller-Stanislawski B. Auswertung der UAW-Meldungen nach Impfung mit pandemischen Influenzaimpfstoffen. Arzneimittel im Blick 2010, 3-8.
10. European Medicines Agency (EMA). Fifteenth pandemic pharmacovigilance update, 8 April 2010, EMA/213238/2010. http://www.ema.europa.eu/influenza/updates.hrml.
11. Folkenberg M., Callreús T., Svanström H., Valentiner-Branth P., Hviid A. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010. Vaccine 2011, 29:1180-1184.
12. Mayet A., Ligier C., Gache K., Manet G., Nivoix P., Dia A., et al. Adverse events following pandemic influenza vaccine PandemrixR reported in the French military forces - 2009-2010. Vaccine 2011, 29:2576-2581.
13. Schroer W.C. Current concepts on the pathogenesis of osteonecrosis of the femoral head. Orthop Rev 1994, 23:487-497.
14. Hasan S.S., Romeo A.A. Nontraumatic osteonecrosis of the humeral head. J Shoulder Elbow Surg 2002, 11:281-298.
15. Gruson K., Kwon Y.W. Atraumatic osteonecrosis of the humeral head. Bull NYU Hosp Jt Dis 2009, 67:6-14.
16. Cooper C., Steinbuch M., Stevenson R., Miday R. The epidemiology of osteonecrosis: findings from the GPRD and THIN databases in the UK. Osteoporos Int 2010, 21:569-577.
17. Mont M.A., Payman R.K., Laporte D.M., Petri M., Jones L.C., Hungerford D.S. Atraumatic osteonecrosis of the humeral head. J Rheumatol 2000, 27:1582-1584.
18. Sarris I., Weiser R., Sotereanos D.G. Pathogenesis and treatment of osteonecrosis of the shoulder. Orthop Clin N Am 2004, 35:397-404.
19. Sakai T., Sugano N., Nishii T., Hananouchi T., Yoshikawa H. Extent of osteonecrosis on MRI predicts humeral head collapse. Clin Orthop Relat Res 2008, 466:1074-1080.
20. Black S., Eskola J., Siegrist C.A., Halsey N., MacDonald N., Law B., et al. Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet 2009, 374:2115-2122.
21. Anderton J.M., Orth M.C., Helm R. Multiple joint osteonecrosis following short-term steroid therapy. J Bone Joint Surg 1982, 64:139-141.
22. Fast A., Alon M., Weiss S., Zer-Aviv F. Avascular necrosis of bone following short-term dexamethasone therapy for brain edema. J Neurosurg 1984, 61:983-985.
23. Taylor L.J. Multifocal avascular necrosis after short-term high-dose steroid therapy. J Bone Joint Surg 1984, 66:431-433.
24. O'Brien T.J., Mack G.R. Multifocal osteonecrosis after short-term high-dose corticosteroid therapy. Clin Orthop 1992, 279:176-179.
25. Laroche M., Arlet J., Mazieres B. Osteonecrosis of the femoral and humeral heads after intraarticular corticosteroid injections. J Rheumatol 1990, 17:549-551.
26. McKee M.D., Waddell J.P., Kudo P.A., Schemitsch E.H., Richards R.R. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. Can Med Assoc J 2001, 164:205-206.
27. Wraith D., Goldman M., Lambert P.H. Vaccination and autoimmune disease: what is the evidence?. Lancet 2003, 362:1659-1666.
28. Agmon-Levin N., Paz Z., Israeli E., Shoenfeld Y. Vaccines and autoimmunity. Nat Rev Rheumatol 2009, 5:648-652.
29. Balofsky A., Agmon-Levin N., Shoenfeld Y. The new H1N1 and HPV vaccines and old fears. Curr Opin Rheumatol 2010, 22:431-436.
30. Damjanov I., Amato J.A. Progression of renal disease in Henoch-Schönlein purpura after influenza vaccination. JAMA 1979, 242:2555-2556.
31. Blumberg S., Bienfang D., Kantrowitz F.G. A possible association between influenza vaccination and small-vessel vasculitis. Arch Intern Med 1980, 140:847-848.
32. Patel U., Bradley J.R., Hamilton D.V. Henoch-Schönlein purpura after influenza vaccination. BMJ 1988, 296:1800.
33. Watanabe T. Henoch-Schönlein purpura following influenza vaccinations during the pandemic of influenza A(H1N1). Pediatr Nephrol 2011, 26:795-798.
34. Uji M., Matsushita H., Iwata S. Microscopic polyangiitis after influenza vaccination. Intern Med 2005, 44:892-896.
35. Conti F., Rezai S., Valesini G. Vaccination and autoimmune rheumatic diseases. Autoimmun Rev 2008, 8:124-128.
36. Stassen P.M., Sanders J.S., Kallenberg C.G., Stegeman C.A. Influenza vaccination does not result in an increase in relapse in patients with ANCA-associated vasculitis. Nephrol Dial Transplant 2008, 23:654-658.
37. Zafrir Y., Agmon-Levin N., Shoenfeld Y. Post-influenza vaccination vasculitides. J Clin Rheumatol 2009, 15:269-270.
38. Birck R., Kaelsch I., Schnuelle P., Flores-Suares L.F., Nowack R. ANCA-associated vasculitis following influenza vaccination: causal association or mere coincidence?. J Clin Rheumatol 2009, 15:289-291.
39. Van Assen S., Elkayam O., Agmon-Levin N., Cervera R., Doran M.F., Dougados M., et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European league against rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory diseases. Autoimmun Rev 2011, 10:341-352.
40. Shoenfeld Y., Agmon-Levin N. 'ASIA'-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011, 36:4-8.
41. Israeli E., Agmon-Levin N., Blank M., Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009, 18:1217-1225.
42. Leroux-Roels G. Prepandemic H5N1 influenza vaccine adjuvanted with AS03: a review of the pre-clinical and clinical data. Expert Opin Biol Ther 2009, 9:1057-1071.
43. Hermann R., Pfeil A., Busch M., Kettner C., Kretzschmar D., Hansch A. Schwerste thrombotisch-thrombozytopenische Purpura (TTP) nach H1N1-Vakzinierung. Med Klin 2010, 105:663-668.